Growth Factors (Blood and Tissue) Market Report

China Growth Factors (Blood and Tissue) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 08, 2023
  • PAGES：206
  • REPORT CODE：GMM1838082
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia. Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.

    This report elaborates on the current development of the Growth Factors (Blood and Tissue) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Johnson & Johnson (USA)

    • FibroGen, Inc (USA)

    • Sanofi (France)

    • Merck Serono (Germany)

    • Janssen Biotech, Inc (USA)

    • Lonza Group (Switzerland)

    • Biopharm GmbH (Germany)

    • Amgen, Inc (USA)

    • Sangamo Therapeutics, Inc (USA)

    • Scil Proteins GmbH (Germany)

    • Reliance GeneMedix Plc (UK)

    • F Hoffmann-La Roche AG (Switzerland)

    • PeproTech, Inc (USA)

    • Chugai Pharmaceutical Co Ltd (Japan)

    • BioMimetic Therapeutics LLC (USA)

    • Biogen, Inc (USA)

    • Bayer HealthCare Pharmaceuticals, Inc (USA)

    • Bolder BioTechnology, Inc (USA)

    • Teva Pharmaceutical Industries Ltd (Israel)

    By Type:

    • Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)

    • Tissue Growth Factors

    By Application:

    • Research lab

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Growth Factors (Blood and Tissue) Market Overview 2018-2029

    • 1.1 China Growth Factors (Blood and Tissue) Industry Development Overview

    • 1.2 China Growth Factors (Blood and Tissue) Industry Development History

    • 1.3 China Growth Factors (Blood and Tissue) Industry Market Size (2018-2029)

    • 1.4 China Growth Factors (Blood and Tissue) Market Analysis by Type from Production Side

      • 1.4.1 China Growth Factors (Blood and Tissue) Production Volume, Production Value and Growth Rate of Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) (2018-2029)

      • 1.4.2 China Growth Factors (Blood and Tissue) Production Volume, Production Value and Growth Rate of Tissue Growth Factors (2018-2029)

    • 1.5 China Growth Factors (Blood and Tissue) Market Analysis by Application from Consumption End

      • 1.5.1 China Growth Factors (Blood and Tissue) Sales Volume, Sales Value and Growth Rate of Research lab (2018-2029)

      • 1.5.2 China Growth Factors (Blood and Tissue) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Growth Factors (Blood and Tissue) Market Analysis by Region

      • 1.6.1 North China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Growth Factors (Blood and Tissue) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Growth Factors (Blood and Tissue) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Growth Factors (Blood and Tissue) Market Status and Competition Analysis in 2023

      • 2.2.3 China Growth Factors (Blood and Tissue) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Growth Factors (Blood and Tissue) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Growth Factors (Blood and Tissue) Industry Development

    Chapter 3 Growth Factors (Blood and Tissue)Industry Chain Analysis

    • 3.1 Growth Factors (Blood and Tissue) Industry Chain

    • 3.2 Growth Factors (Blood and Tissue) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Growth Factors (Blood and Tissue) Market

    • 3.3 Growth Factors (Blood and Tissue) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Growth Factors (Blood and Tissue) Market

    Chapter 4 China Growth Factors (Blood and Tissue) Market, by Type

    • 4.1 China Growth Factors (Blood and Tissue) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Growth Factors (Blood and Tissue) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Growth Factors (Blood and Tissue) Production Volume and Growth Rate, by Type

      • 4.5.1 China Growth Factors (Blood and Tissue) Production Volume and Growth Rate of Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)

      • 4.5.2 China Growth Factors (Blood and Tissue) Production Volume and Growth Rate of Tissue Growth Factors

    Chapter 5 China Growth Factors (Blood and Tissue) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Growth Factors (Blood and Tissue) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Growth Factors (Blood and Tissue) Market Size and Growth Rate, by Application

      • 5.5.1 China Growth Factors (Blood and Tissue) Market Size and Growth Rate of Research lab

      • 5.5.2 China Growth Factors (Blood and Tissue) Market Size and Growth Rate of Hospital

    Chapter 6 China Growth Factors (Blood and Tissue) Market, by Region

    • 6.1 China Growth Factors (Blood and Tissue) Production Volume and Production Value, by Region

    • 6.2 China Growth Factors (Blood and Tissue) Sales Volume and Sales Value, by Region

    Chapter 7 North China Growth Factors (Blood and Tissue) Market Analysis

    • 7.1 North China Growth Factors (Blood and Tissue) Market, by Type

    • 7.2 North China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 8 Central China Growth Factors (Blood and Tissue) Market Analysis

    • 8.1 Central China Growth Factors (Blood and Tissue) Market, by Type

    • 8.2 Central China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 9 South China Growth Factors (Blood and Tissue) Market Analysis

    • 9.1 South China Growth Factors (Blood and Tissue) Market, by Type

    • 9.2 South China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 10 East China Growth Factors (Blood and Tissue) Market Analysis

    • 10.1 East China Growth Factors (Blood and Tissue) Market, by Type

    • 10.2 East China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 11 Northeast China Growth Factors (Blood and Tissue) Market Analysis

    • 11.1 Northeast China Growth Factors (Blood and Tissue) Market, by Type

    • 11.2 Northeast China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 12 Southwest China Growth Factors (Blood and Tissue) Market Analysis

    • 12.1 Southwest China Growth Factors (Blood and Tissue) Market, by Type

    • 12.2 Southwest China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 13 Northwest China Growth Factors (Blood and Tissue) Market Analysis

    • 13.1 Northwest China Growth Factors (Blood and Tissue) Market, by Type

    • 13.2 Northwest China Growth Factors (Blood and Tissue) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Johnson & Johnson (USA)

        • 14.1.1 Johnson & Johnson (USA) Company Profile

        • 14.1.2 Johnson & Johnson (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 FibroGen, Inc (USA)

        • 14.2.1 FibroGen, Inc (USA) Company Profile

        • 14.2.2 FibroGen, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sanofi (France)

        • 14.3.1 Sanofi (France) Company Profile

        • 14.3.2 Sanofi (France) Growth Factors (Blood and Tissue) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck Serono (Germany)

        • 14.4.1 Merck Serono (Germany) Company Profile

        • 14.4.2 Merck Serono (Germany) Growth Factors (Blood and Tissue) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Janssen Biotech, Inc (USA)

        • 14.5.1 Janssen Biotech, Inc (USA) Company Profile

        • 14.5.2 Janssen Biotech, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Lonza Group (Switzerland)

        • 14.6.1 Lonza Group (Switzerland) Company Profile

        • 14.6.2 Lonza Group (Switzerland) Growth Factors (Blood and Tissue) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Biopharm GmbH (Germany)

        • 14.7.1 Biopharm GmbH (Germany) Company Profile

        • 14.7.2 Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Amgen, Inc (USA)

        • 14.8.1 Amgen, Inc (USA) Company Profile

        • 14.8.2 Amgen, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sangamo Therapeutics, Inc (USA)

        • 14.9.1 Sangamo Therapeutics, Inc (USA) Company Profile

        • 14.9.2 Sangamo Therapeutics, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Scil Proteins GmbH (Germany)

        • 14.10.1 Scil Proteins GmbH (Germany) Company Profile

        • 14.10.2 Scil Proteins GmbH (Germany) Growth Factors (Blood and Tissue) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Reliance GeneMedix Plc (UK)

        • 14.11.1 Reliance GeneMedix Plc (UK) Company Profile

        • 14.11.2 Reliance GeneMedix Plc (UK) Growth Factors (Blood and Tissue) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 F Hoffmann-La Roche AG (Switzerland)

        • 14.12.1 F Hoffmann-La Roche AG (Switzerland) Company Profile

        • 14.12.2 F Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 PeproTech, Inc (USA)

        • 14.13.1 PeproTech, Inc (USA) Company Profile

        • 14.13.2 PeproTech, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Chugai Pharmaceutical Co Ltd (Japan)

        • 14.14.1 Chugai Pharmaceutical Co Ltd (Japan) Company Profile

        • 14.14.2 Chugai Pharmaceutical Co Ltd (Japan) Growth Factors (Blood and Tissue) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 BioMimetic Therapeutics LLC (USA)

        • 14.15.1 BioMimetic Therapeutics LLC (USA) Company Profile

        • 14.15.2 BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Biogen, Inc (USA)

        • 14.16.1 Biogen, Inc (USA) Company Profile

        • 14.16.2 Biogen, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Bayer HealthCare Pharmaceuticals, Inc (USA)

        • 14.17.1 Bayer HealthCare Pharmaceuticals, Inc (USA) Company Profile

        • 14.17.2 Bayer HealthCare Pharmaceuticals, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Bolder BioTechnology, Inc (USA)

        • 14.18.1 Bolder BioTechnology, Inc (USA) Company Profile

        • 14.18.2 Bolder BioTechnology, Inc (USA) Growth Factors (Blood and Tissue) Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Teva Pharmaceutical Industries Ltd (Israel)

        • 14.19.1 Teva Pharmaceutical Industries Ltd (Israel) Company Profile

        • 14.19.2 Teva Pharmaceutical Industries Ltd (Israel) Growth Factors (Blood and Tissue) Market Performance

        • 14.19.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Growth Factors (Blood and Tissue) Industry Research Conclusions

    • 15.2 Growth Factors (Blood and Tissue) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Growth Factors (Blood and Tissue) Industry Market Size (2018-2029)

    • Figure China Growth Factors (Blood and Tissue) Production Volume, Production Value and Growth Rate of Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) (2018-2029)

    • Figure China Growth Factors (Blood and Tissue) Production Volume, Production Value and Growth Rate of Tissue Growth Factors (2018-2029)

    • Figure China Growth Factors (Blood and Tissue) Sales Volume, Sales Value and Growth Rate of Research lab (2018-2029)

    • Figure China Growth Factors (Blood and Tissue) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure Central China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure South China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure East China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Growth Factors (Blood and Tissue) Market Size and Growth Rate from 2018-2029

    • Figure Growth Factors (Blood and Tissue) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Growth Factors (Blood and Tissue) Market Share by Type in 2018

    • Figure China Growth Factors (Blood and Tissue) Market Share by Type in 2023

    • Figure China Growth Factors (Blood and Tissue) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Production Volume and Growth Rate of Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins) (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Production Volume and Growth Rate of Tissue Growth Factors (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Market Share by Application in 2018

    • Figure China Growth Factors (Blood and Tissue) Market Share by Application in 2023

    • Figure China Growth Factors (Blood and Tissue) Total Market Size and Growth Rate from Consumption End

    • Figure China Growth Factors (Blood and Tissue) Market Size and Growth Rate of Research lab (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Production Volume by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Production Volume Share by Region (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Production Volume Share by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Production Value by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Production Value Share by Region (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Production Value Share by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Sales Volume by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Sales Volume Share by Region (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Sales Volume Share by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Sales Value by Region (2018-2023)

    • Table China Growth Factors (Blood and Tissue) Sales Value Share by Region (2018-2023)

    • Figure China Growth Factors (Blood and Tissue) Sales Value Share by Region (2018-2023)

    • Table North China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table North China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure North China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table North China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table North China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure North China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table Central China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table Central China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure Central China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table Central China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table Central China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure Central China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table South China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table South China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure South China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table South China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table South China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure South China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table East China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table East China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure East China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table East China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table East China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure East China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table Northeast China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table Northeast China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table Northeast China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table Southwest China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table Southwest China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table Southwest China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Growth Factors (Blood and Tissue) Production Volume by Type (2018-2023)

    • Table Northwest China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Growth Factors (Blood and Tissue) Production Volume Share by Type (2018-2023)

    • Table Northwest China Growth Factors (Blood and Tissue) Sales Volume by Application (2018-2023)

    • Table Northwest China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Growth Factors (Blood and Tissue) Sales Volume Share by Application (2018-2023)

    • Table Johnson & Johnson (USA) Company Profile

    • Table Johnson & Johnson (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table FibroGen, Inc (USA) Company Profile

    • Table FibroGen, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Sanofi (France) Company Profile

    • Table Sanofi (France) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Merck Serono (Germany) Company Profile

    • Table Merck Serono (Germany) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Janssen Biotech, Inc (USA) Company Profile

    • Table Janssen Biotech, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Lonza Group (Switzerland) Company Profile

    • Table Lonza Group (Switzerland) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Biopharm GmbH (Germany) Company Profile

    • Table Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc (USA) Company Profile

    • Table Amgen, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Sangamo Therapeutics, Inc (USA) Company Profile

    • Table Sangamo Therapeutics, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Scil Proteins GmbH (Germany) Company Profile

    • Table Scil Proteins GmbH (Germany) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Reliance GeneMedix Plc (UK) Company Profile

    • Table Reliance GeneMedix Plc (UK) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG (Switzerland) Company Profile

    • Table F Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table PeproTech, Inc (USA) Company Profile

    • Table PeproTech, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Co Ltd (Japan) Company Profile

    • Table Chugai Pharmaceutical Co Ltd (Japan) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table BioMimetic Therapeutics LLC (USA) Company Profile

    • Table BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Biogen, Inc (USA) Company Profile

    • Table Biogen, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Pharmaceuticals, Inc (USA) Company Profile

    • Table Bayer HealthCare Pharmaceuticals, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Bolder BioTechnology, Inc (USA) Company Profile

    • Table Bolder BioTechnology, Inc (USA) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Company Profile

    • Table Teva Pharmaceutical Industries Ltd (Israel) Growth Factors (Blood and Tissue) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US